美股期權個股詳情

NVRO241220P15000

添加自選

4.50
0.000.00%

延時15分鐘行情收盤價 11/19 16:00 (美東)

0.00最高價0.00最低價

Nevro股票討論

登錄發表評論

Trytosaveabit

11/12 06:07

更新

$Nevro (NVRO.US)$ 路透社
6 分鐘前
nevro的Hfx Iq™脊椎神經刺激搭載人工智能科技，在歐洲獲得CE標誌認證，全球產品擴展規模增加

已翻譯

Stock_Drift

11/11 16:19

夜間交易。5:18pm

$Impact BioMedical (IBO.US)$ $艾切托 (ACET.US)$ $Zoomcar Holdings (ZCAR.US)$ $Ryde Group (RYDE.US)$ $Foresight Autonomous (FRSX.US)$ $Check-Cap (CHEK.US)$ $Nvni Group (NVNI.US)$ $Bridger Aerospace (BAER.US)$ $淘屏 (TAOP.US)$ $思享無限 (SJ.US)$ $Nevro (NVRO.US)$ $Taysha Gene Therapies (TSHA.US)$ $MultiMetaVerse (MMV.US)$ $XBP Europe Holdings (XBP.US)$

已翻譯

Jaguar8

09/24 07:02

新聞

$Nevro (NVRO.US)$
內夫羅宣布推出 HFX 適應性 AI™，這是脊髓刺激中唯一的人工智能驅動技術
尼佛羅公司（紐約證券交易所：NVRO）宣布獲 FDA 批准和市場推出 HFX iQ™，這是一種用於慢性疼痛管理的人工智能驅動脊髓刺激 (SCS) 系統 HFX iQ。™該技術利用來自 100,000 多名患者的見解和 10000 萬多個數據點，實時提供個性化、響應式的疼痛緩解。
HFX 適應技術的主要特點

已翻譯

Newbee4

08/08 06:22

Do you have any thoughts on this?

$Nevro (NVRO.US)$ @Trytosaveabit

Moomoo AI

02/25 07:35

Nevro's low P/S ratio may be due to its poor revenue outlook. Shareholders accept this as they anticipate no future revenue surprises. These conditions could continue to limit the share price.

Benign Growth For Nevro Corp. (NYSE:NVRO) Underpins Its Share Price

Moomoo AI

01/08 11:41

Nevro's growth strategy, prioritizing expansion over steady profits, is viewed as risky, leading to a rapidly declining share price. Despite insider purchases, the company's overall performance has been disappointing, resulting in an annual loss of 8% for shareholders over five years.

Shareholders in Nevro (NYSE:NVRO) Have Lost 89%, as Stock Drops 10% This Past Week

Moomoo AI

2023/11/16 06:30

過去一年內，內部人士買入股票，包括有人以高於現時價格購買，顯示對公司未來的積極看法。近三個月沒有任何內部人士交易，但過去一年的活動表明對潛力持有堅定信念。

已翻譯

nevro內部人士在這一年中增持股份59%

Moomoo AI

2023/10/10 07:38

The disappointing performance of Nevro's stock may be due to low growth and profit rates. Despite insider purchases, market sentiment towards Nevro remains negative, possibly an overreaction.

Further Weakness as Nevro (NYSE:NVRO) Drops 9.3% This Week, Taking Three-year Losses to 88%

Moomoo AI

2023/10/10 07:30

Despite Nevro's stock price plummeting, insiders buying shares in the past year, the company's ascent looks doubtful without significant profits and revenue growth.

Further Weakness as Nevro (NYSE:NVRO) Drops 9.3% This Week, Taking Three-year Losses to 88%

Movers and Shakers

2022/10/10 07:55

專欄今日市前股票走勢：RIVN、EDU、TLRY、F 等

缺口
最新消息:
• $PyroGenesis Canada (PYR.US)$ +5.9%（宣布關於破壞 PFAS 合同的陸地系統的談判已暫停並停止）
• $Immatics (IMTX.US)$ 增加 3.1%（宣布 IMA203 的臨床數據更新）
• $iPATH 標普500 VIX短期期貨ETN (VXX.US)$ +1.6%（隨期貨軟化而上升）
• $Nevro (NVRO.US)$ 增加 1.4%（對於評論） $聯合健康 (UNH.US)$ 醫療保障政策 u...

已翻譯

暫無評論